Protective measures

Protective measures against SARS‑CoV‑2

All practices and processes applied by the Group hospitals demonstrate our transparent commitment to continue improving the quality and safety of the care provided to our patients.

From the very first moment the first coronavirus case was identified in Greece, our hospitals responded immediately, implementing all the necessary measures to safeguard their facilities, protecting the health of their patients and employees.

Infection Control Committee

Assisted by the competent Infection Control Committee (ICC), at MITERA we apply all the approved operational rules and safety protocols, strictly taking into account the guidelines issued by the National Public Health Organization (NPHO), the Greek Ministry of Health and international organizations.

Guided by distinguished infectious disease specialists, the ICC ensures continuous updates regarding the developments with COVID-19, actively contributes in overseeing and organizing safety protocols, and remains on alert when it comes to monitoring the seamless and safe operation of the Hospital. It mainly focuses on ensuring that all the hospital departments work closely together and the staff receive continuous updates and training.

Operating Guidelines

The following precautionary measures have been taken to avoid overcrowding in waiting areas:

For consultations at doctor’s offices (regular visits) a COVID test is NOT required. However, the personal protection measures must be followed.
Patient appointments are scheduled depending on the required time for the examination, so as to avoid crowding of patients in the waiting areas.
The doctor’s offices are adequately ventilated, preferably naturally. Where natural ventilation is not possible, the air is renewed through central air conditioning units, in accordance with the instructions in the Ministry of Health circular with ref. no. Δ1(δ)/ΓΠ οικ. 26635.
As soon as the patients leave, all surfaces and medical equipment used during the exam are cleaned/disinfected, as per the approved guidelines issued by the Infection Control Committee.
Instructions for visitors and patients are posted in various spots throughout the hospital.
The Infection Control Committee ensures continuous updates regarding the developments with COVID-19, actively contributes to overseeing and organizing safety protocols, and remains on alert when it comes to monitoring the seamless and safe operation of the hospital.

Τhe Infection Control Committee ensures continuous updates regarding the developments with COVID-19, actively contributes in overseeing and organizing safety protocols, and remains on alert when it comes to monitoring the seamless and safe operation of the Hospital.

Carers – General Hospital

One visitor / carer per shift is allowed.

People with a respiratory infection are NOT allowed to visit.

The carers of patients hospitalized in the General / Maternity / Gynecological Clinic are checked with a rapid test which is repeated every 4 days in long-term hospitalizations. For visiting the ICU, a rapid test is required, which is repeated every 4 days, and the use of a mask.

Carers – Children’s Hospital

The carers/vistirors at the Pediatric Clinic perform a rapid test upon admission of the pediatric patient. Re-check is carried out on indications (new respiratory infection).

Carers - NICU & ICU Pediatric Cardiosurgical

No screening is required except use of the mask and hand hygiene.

Measures for patients

Rapid antigen test is required in all patients with symptoms of respiratory infection or other symptoms compatible with COVID-19 infection who:

a) They will be admitted to the hospital

b) they will be examined at the Outpatient – Emegrency Dept.

If the antigen detection test is negative, a rapid molecular test for respiratory viruses (SARS – CoV-2, RSV, influenza A, B) is performed.

For pediatric patients with symptoms of respiratory infection, a rapid test is performed. In the case of a negative result, further testing (molecular) is carried out at the discretion of the attending physician.

For outpatient ICU admission, molecular testing is required.

Unstable patients who are already hospitalized at MITERA and need immediate transfer to the ICU, undergo an antigen test (rapid test) and a rapid molecular test. The patient is immediately transferred to the ICU after receiving the result.